Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Otsuka American Pharmaceutical Inc.
Current Parent Company: Otsuka Pharmaceutical
Penalty: $1,700,000
Year: 2008
Date: March 27, 2008
Offense Group: healthcare-related offenses
Primary Offense: off-label or unapproved promotion of medical products
Secondary Offense: False Claims Act and related
Violation Description: Otsuka American Pharmaceutical agreed to $1.7 million to settle multistate litigation alleging it engaged in off-label marketing of the schizophrenia drug Abilify and thus cased false claims to be submitted to state Medicaid programs. This was part of a larger $4 million settlement involving the federal government; see the Violation Tracke entry at (click here)
Level of Government: state
Action Type: agency action
Agency: Multistate Attorneys General Case
Civil or Criminal Case: civil
HQ Country of Current Parent: Japan
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.